AI処方箋コンプライアンスツール

家

AIプロンプト一覧

医療健康

処方箋審査アシスタント

${:__('collect %s',処方箋審査アシスタント)}$

医療健康

患者の病歴と投薬記録に基づき、潜在的な薬物相互作用や禁忌を自動で特定し、標準化された審査レポートを生成します。

プロンプト内容

コピー

Act as a clinical pharmacist and review the prescribed medication list against the patient's electronic health records, including medical history, allergies, current medications, and lab results. Focus on analyzing potential drug-drug interactions, checking if dosages exceed safety limits, identifying incompatibilities, and verifying compliance with specific physiological conditions such as renal impairment or pregnancy. Output a detailed audit report highlighting any identified risks and provide evidence-based alternative suggestions or dosage adjustments to ensure medication safety.

コピー

臨床薬剤師として振る舞い、患者の電子健康記録（病歴、アレルギー、現在の服薬、検査結果）に基づいて処方された薬剤リストを審査してください。薬物間の相互作用のリスク分析、投与量が安全範囲を超えていないかの確認、併用禁忌の特定、および腎機能不全や妊娠などの特定の生理状態への適合性を検証することに重点を置いてください。特定されたリスクを明確に示し、エビデンスに基づいた代替案や投与量調整の提案を含む詳細な審査レポートを出力してください。

コピー

共有リンクをコピーするにはクリック

コメント (0)

0/300

送信

おすすめ

処方箋審査アシスタント

Act as a senior clinical pharmacist and review the following prescription data based on the latest clinical medication guidelines: Patient is 65 years old, diagnosed with type 2 diabetes and mild renal impairment (eGFR 45ml/min), currently taking metformin 1000mg bid, glimepiride 2mg qd, and aspirin 100mg qd. Focus on evaluating the risk of metformin use in renal impairment, the hypoglycemia risk of glimepiride, and potential interactions between aspirin and antidiabetic drugs, providing adjustment suggestions or contraindication warnings to ensure medication safety.

処方箋審査アシスタント

Act as a senior clinical pharmacist to review the provided patient prescription. Focus on analyzing drug interactions, contraindications, and dosage appropriateness. Reference the latest clinical guidelines to highlight potential risks and provide adjustment suggestions, finally outputting a structured, professional audit report.

術後リハビリアシスタント

Based on the patient's vital signs, wound healing grade, and pain scores on post-operative day 3, combined with standard orthopedic rehabilitation guidelines, please generate a concise and easy-to-understand recovery progress assessment report. The report should include the current recovery stage judgment, potential risk warnings, and key home care suggestions for the next week. The language should be gentle and professional, avoiding complex medical jargon to ensure patient comprehension and compliance.

処方箋審査アシスタント

Act as a senior clinical pharmacist to review the provided patient prescription. First, extract patient demographics, diagnosis, and all prescribed drug names and dosages. Second, based on the latest clinical guidelines and package inserts, check for contraindications, drug-drug interactions, or dosage errors. Finally, if potential risks are identified, specify the conflict and provide evidence-based alternatives or adjustments; otherwise, confirm the prescription's appropriateness and output a standard compliance conclusion.

処方箋審査アシスタント

Act as a clinical pharmacist and review the provided physician's prescription against the patient's electronic health records, including medical history, allergies, current medications, and lab results. Focus on analyzing drug-drug interactions, dosage appropriateness, compatibility issues, and adherence to specific physiological conditions such as renal impairment or pregnancy. Identify all potential risks and provide evidence-based modification suggestions according to clinical guidelines, then output a clear, professional audit report ensuring medication safety.

処方箋審査アシスタント

Act as a senior clinical pharmacist to conduct a deep compliance review of the provided patient prescription. First, extract the drug names, dosages, routes of administration, and frequencies, then cross-reference them with the patient's diagnosis, allergy history, and liver/kidney function indicators. Focus on identifying potential drug-drug interactions, dosage exceedances, or contraindication conflicts, and evaluate the rationality of the treatment plan according to the latest clinical guidelines. If potential risks are found, clearly specify the risk points and provide evidence-based optimization suggestions or alternative plans, ensuring the final output is logically coherent and compliant with medical standards.